Contents

Current Pharmaceutical Design, Volume 16 - Number 35

Editorial [Hot topic: Anti-Angiogenic Agents (Executive Editor: Maurizio Botta and Anna Di Donna)]

, 16(35): 3862 - 3863

Anna Di Donna


DOI: 10.2174/138161210794454978




Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?

, 16(35): 3864 - 3876

Carine Munaut, Alain C. Colige and Charles A. Lambert


DOI: 10.2174/138161210794455012




Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets

, 16(35): 3877 - 3894

Magdalena Tertil, Alicja Jozkowicz and Jozef Dulak


DOI: 10.2174/138161210794454969




Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation

, 16(35): 3895 - 3902

Esma R. Isenovic, Sanja Soskic, Andreja Trpkovic, Branislava Dobutovic, Milan Popovic, Zoran Gluvic, Biljana Putnikovic and Pierre Marche


DOI: 10.2174/138161210794454987




CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

, 16(35): 3903 - 3920

S. Liekens, D. Schols and S. Hatse


DOI: 10.2174/138161210794455003




Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies

, 16(35): 3921 - 3931

Michele Moschetta, Marta Cesca, Francesca Pretto and Raffaella Giavazzi


DOI: 10.2174/138161210794455021




Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies

, 16(35): 3932 - 3957

Ana R. Quesada, Miguel Angel Medina, Ramon Munoz-Chapuli and Angel Luis G. Ponce


DOI: 10.2174/138161210794454950




Imaged-based High-Throughput Screening for Anti-Angiogenic Drug Discovery

, 16(35): 3958 - 3963

Lasse Evensen, Wolfgang Link and James B. Lorens


DOI: 10.2174/138161210794455030




Using Insights into Pim1 Structure to Design New Anticancer Drugs

, 16(35): 3964 - 3978

Silvia Schenone, Cristina Tintori and Maurizio Botta


DOI: 10.2174/138161210794454996




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science